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OBJECTIVE — To study the association of serum fetuin-A as a potential risk factor with
abnormal albuminuria in Chinese individuals with normal glucose tolerance (NGT).
RESEARCH DESIGN AND METHODS — The cross-sectional analysis included 607
men and 1,042 women aged 40 or older with NGT.
RESULTS — Women with combined microalbuminuria and macroalbuminuria (n  68)
had signiﬁcantly higher serum fetuin-A concentrations than those with normal albumin
excretion (n  974) (314.3 vs. 280.4 mg/l, P  0.007). Compared with the lowest quartile,
the highest quartile of serum fetuin-A had 40% increased risk of abnormal albuminuria after
the multiple adjustments in women (Pfor trend  0.02). However, the associations were not
detected in men.
CONCLUSIONS — Higher serum fetuin-A was associated with abnormal albuminuria in-
dependent of BMI, waist circumference, homeostasis model assessment of insulin resistance,
blood pressure, and other determinants of albuminuria in middle-aged and elderly Chinese
women with NGT.
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F
etuin-A, which is predominantly se-
creted by the liver, is found to be
related to the accumulation of fat in
the liver, insulin resistance (1), type 2 di-
abetes (2), and cardiovascular diseases
(CVDs) (3,4). Microalbuminuria is asso-
ciated with insulin resistance (5,6) and
represents a risk factor for CVDs regard-
less of diabetes status (7). We aimed to
study the association of higher serum fe-
tuin-A as a potential risk factor with
abnormal albuminuria in Chinese indi-
viduals with normal glucose tolerance
(NGT).
RESEARCH DESIGN AND
METHODS— This cross-sectional in-
vestigation was conducted among 1,649
participants(607menand1,042women)
aged 40 years or older with NGT who
were recruited from a community-based
glucose survey (8). The Institutional Re-
view Board of Ruijin Hospital, Shanghai
Jiao-Tong University School of Medicine,
approved the study protocol, and all the
participants gave written informed
consent.
Fasting and 2-h postprandial plasma
glucose were measured using an auto-
mated biochemical instrument (Beckman
CX-7 Biochemical Autoanalyzer; Brea,
CA). Serum insulin was measured by a
radioimmunoassay (Sangon Company,
Shanghai, China).Urinary albumin and
creatinine concentrations were deter-
mined using the ﬁrst void sterile urine
sampleintheearlymorningbyrateneph-
elometry (Beckman Coulter, Fullerton,
CA) and alkaline nitroxanthic acid
method, respectively. Serum fetuin-A
concentrations were measured by en-
zyme-linkedimmunosorbentassay(R&D
Systems, Minneapolis, MN), and the in-
traassay and interassay coefﬁcient of vari-
ation was 5.2 and 7.8%, respectively.
Fasting plasma glucose 6.1 mmol/l
and postprandial plasma glucose 7.8
mmol/l and without taking any antidia-
betic treatment were deﬁned as NGT ac-
cording to the 1999 World Health
Organization (WHO) criteria (9). BMI
was categorized as normal weight (23
kg/m
2, n  375) and overweight or obese
(23 kg/m
2, n  667) (10). The albu-
min-to-creatinine ratio (ACR) was used
for the diagnosis of abnormal albumin-
uria, and was deﬁned as an ACR 30
mg/g. The abbreviated Modiﬁcation of
Diet in Renal Disease (MDRD) Study
Group formula was used to calculate the
estimated glomerular ﬁltration rate
(eGFR) (11). Chronic kidney disease was
deﬁnedaseGFR60ml/minper1.73m
2
(n  166).
Analysis was performed on SAS ver-
sion 8.1 (SAS Institute, Cary, NC). Com-
parisons of means and proportions were
performed with the standard normal Z
test and 
2 test. The unadjusted and
multivariate adjusted logistic regression
analysis was used to investigate the asso-
ciations between abnormal abuminuria
and serum fetuin-A concentrations. A P
value 0.05 was considered statistically
signiﬁcant.
RESULTS— The prevalence of abnor-
mal albuminuria was 4.5% in men and
6.5% in women. Women with abnormal
albuminuria had higher serum fetuin-A
concentrations than those with normal
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P  0.007). Among women, the preva-
lence of abnormal albuminuria gradually
increased across the fetuin-A quartiles.
Compared with the lowest quartile, the
highest quartile of serum fetuin-A had
40% increased risk of abnormal albumin-
uria (Pfor trend  0.02) after the multiple
adjustments (Table 1). After excluding
subjects with chronic kidney disease, the
result was not radically changed. How-
ever, these associations did not appear in
men (online appendix Table 1 and online
appendix Fig. 1, available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc10-0595/DC1 and
in Table 1). The prevalence of the abnor-
mal albuminuria was 7.2% in women
whowereoverweightandobeseand5.3%
in women with normal weight. Each 1 SD
increase of fetuin-A was associated with
abnormal albuminuria among women
whowereoverweightandobese(oddsra-
tio [OR] 1.38 [95% CI 1.05–1.7], P 
0.02),whereastheassociationdidnotap-
pear in women with normal weight (0.95
[0.56–1.45], P  0.84).
CONCLUSIONS — To our knowl-
edge, this is the ﬁrst study to explore the
association between serum fetuin-A and
abnormal albuminuria in NGT subjects.
Higher serum fetuin-A was associated
with abnormal albuminuria independent
of the traditional determinants of albu-
minuria in middle-aged and elderly Chi-
nese women with NGT.
Fetuin-A was associated with insulin
resistance (1,12). It is possible that the
role of fetuin-A in mediating insulin
resistance may underlie the association
between fetuin-A and abnormal albumin-
uria. However, the association was
independent of homeostasis model as-
sessmentofinsulinresistanceindexinthe
present study, suggesting that insulin re-
sistance might partially determine the re-
lation between fetuin-A and abnormal
albuminuria. Other potential mecha-
nisms, such as low-grade inﬂammation
(13), could link fetuin-A with elevated
urinary albumin excretion (UAE). Addi-
tionally, further adjustment for waist
circumference did not change the associ-
ation between fetuin-A and abnormal al-
buminuria. Liver fat and its secreted
products,suchasfetuin-A,mightbemore
promising in the determination of the
metabolicriskthanmeasurementofwaist
circumference, adiponectin, or visceral
fat(14).Thus,theassociationbetweenfe-
tuin-A and abnormal albuminuria might
be mediated by increased liver fat instead
oforindependentofwaistcircumference.
However, without precise measurements
of body fat distribution, the underlying
mechanism cannot be drawn from our
study.
Higher fetuin-A was reported to be
more strongly associated with a higher
CVD risk in women than in men (5). We
found a signiﬁcant interaction between
sexandserumfetuin-Afortheassociation
with abnormal albuminuria. A more
likely explanation is that more metabolic
factors were associated with urinary ACR
in men with NGT than those in women
(online appendix Table 1), which might
overcome and veil the effect of fetuin-A
on the UAE in men. However, the power
is 23% in men to ﬁnd an OR of 1.40 in
women given that the prevalence of ab-
normal albuminuria in men is 4.5%.
Thus, we cannot exclude a signiﬁcant as-
sociationofserumfetuin-Aandabnormal
albuminuriainmenduetoarelativesmall
sample size. Potential sex-speciﬁc associ-
ations between fetuin-A and abnormal al-
buminuria need to be elucidated.
However, the principal limitation of
our study was its cross-sectional design,
and no causal inference can be drawn.
Also, when evaluating UAE, we did not
collect 24-h urine. Although ACR in the
ﬁrst morning urine sample is less precise,
it was reported to well agree with 24-h
UAE and could be a reliable alternative in
epidemiological studies (15).
In summary, higher serum fetuin-A
was independently associated with ab-
normal albuminuria in middle-aged and
elderly Chinese women with NGT. Pro-
spectivestudiesarerequiredtodetermine
the role of fetuin-A in the development of
abnormal albuminuria and CVDs.
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Table 1—Association between fetuin-A and abnormal albuminuria
Unadjusted Model 1 Model 2 Model 3 Model 4
Men (n  607)
Quartile 1 (235.6 mg/l) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Quartile 2 (235.6–292.5 mg/l) 1.18 (0.39–3.61) 1.62 (0.44–6.02) 2.25 (0.51–9.56) 2.21 (0.52–9.45) 2.18 (0.48–9.86)
Quartile 3 (292.5–368.6 mg/l) 1.08 (0.62–1.89) 0.98 (0.52–1.87) 0.68 (0.32–1.43) 0.69 (0.33–1.46) 0.59 (0.25–1.37)
Quartile 4 ( 368.6 mg/l) 1.06 (0.73–1.53) 1.03 (0.67–1.57) 0.97 (0.59–1.57) 0.93 (0.57–1.53) 0.90 (0.54–1.52)
Pfor trend 0.79 0.88 0.63 0.60 0.45
1 SD increase of fetuin-A 0.89 (0.54–1.28) 0.80 (0.47–1.21) 0.75 (0.42–1.12) 0.74 (0.41–1.19) 0.70 (0.38–1.16)
Women (n  1,042)
Quartile 1 (233.9 mg/l) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
Quartile 2 (233.9–283.0 mg/l) 1.28 (0.57–2.88) 1.12 (0.48–2.60) 1.10 (0.47–2.58) 1.08 (0.46–2.53) 1.09 (0.46–2.58)
Quartile 3 (283.0–355.6 mg/l) 1.26 (0.85–1.85) 1.27 (0.85–1.91) 1.28 (0.85–1.91) 1.27 (0.85–1.91) 1.27 (0.85–1.91)
Quartile 4 (355.6 mg/l) 1.36 (1.07–1.73) 1.37 (1.07–1.76) 1.39 (1.08–1.80) 1.40 (1.08–1.81) 1.40 (1.08–1.81)
P for trend 0.008 0.01 0.01 0.02 0.02
1 SD increase of fetuin-A 1.30 (1.05–1.58) 1.28 (1.02–1.56) 1.26 (1.01–1.55) 1.26 (1.01–1.55) 1.26 (1.01–1.55)
Data are OR (95% CI). We deﬁned participants with the normal UAE as 0 and abnormal albuminuria (microalbuminuria and macroalbuminuria) as 1. Model 1:
adjusted for age, family history of diabetes, smoking habits, and alcohol intake, systolic blood pressure, diastolic blood pressure, serum high-sensitivity-C-reactive
protein, and eGFR; Model 2: further adjusted for serum triglyceride, total cholesterol, HDL cholesterol, and LDL cholesterol based on Model 1; Model 3: further
adjusted for homeostasis model assessment of insulin resistance based on Model 2; Model 4: further adjusted for BMI and waist circumference based on Model 3.
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